4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Aspire Biopharma Holdings, Inc. (ASBP) operates in the Biotechnology industry and is headquartered in Estero, United States. Its market capitalization is roughly $9 million. In the fiscal year ended 2025-12-31, ASBP reported $0M in revenue and ($24M) in net income.
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States.
Interactive charts & full statements → Open the ASBP valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Gross Profit | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($19M) | ($1M) | ($1M) | ($1M) |
| Net Income | ($24M) | ($1M) | $4M | ($1M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Gross Profit | $0M | $0M | $0M | — | $0M | — |
| Operating Income (EBIT) | ($2M) | ($2M) | ($1M) | ($1M) | ($16M) | — |
| Net Income | ($3M) | ($5M) | ($2M) | ($2M) | ($16M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $1M | $0M | $0M | $0M |
| Total Liabilities | $8M | $2M | $0M | $0M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ASBP viewer.
About TickerBase · Data methodology & sources